FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316657621> ?p ?o ?g. }

• W2316657621 endingPage "e1359" @default.
• W2316657621 startingPage "e1359" @default.
• W2316657621 abstract "Various predictive and prognostic factors could affect breast carcinoma behavior, but to date no definitive correlation has been established between them and breast carcinoma subtypes. The present study was conducted to examine the interrelationships of these predictive and prognostic factors as well as their effects on breast carcinoma subtypes. The archives of all patients with breast carcinoma (from 2008 to 2014) were studied. Patients’ data were extracted using a checklist that included age, histology type, size and grade of tumor, lymph node involvement, estrogen receptor (ER) and progesterone receptor (PR) status, along with the overexpression of human epidermal growth factor receptor (HER2/neu) and the rate of Ki67 and p53 mutations. All data were analyzed by SPSS-17 software with χ2 and Fisher exact tests, as well as the least significant difference pairwise comparison test. A total of 566 patients’ records were included in this study. The mean age of patients was 50 ± 12.9 with an age range of 17 to 98 years. A meaningful correlation was found between age and the type of tumor (P = 0.001). Infiltrating lobular carcinoma had a higher ER positivity between groups (85.7%), whereas noninvasive carcinomas had a higher PR positivity (67%). In addition, a meaningful correlation was detected between the type and grade of tumor (P = 0.001). No meaningful relationship was observed between the type of tumor and HER2/neu overexpression and number of lymph nodes involved. Between the groups, medullary carcinoma had the highest Ki67 index (P = 0.007). Meaningful correlation was found between the grade of tumor and lymph node involvement (P = 0.005) and also with HER2/neu overexpression (P = 0.002). Higher grades had greater positivity in Ki67 index and p53 mutation rates (P = 0.002, P = 0.01). HER2/neu positive tumors had a higher Ki67 index (P = 0.03). Higher Ki67 index tumors showed more HER2/neu overexpression, larger size, and more lymph node involvement compared with other types and maybe considered aggressive. Moreover, in young patients with breast carcinoma, the rates of Ki67 with the overexpression of HER2/neu and p53 mutations are higher, and it shows a more aggressive behavior than other tumors assessed in this age group." @default.
• W2316657621 created "2016-06-24" @default.
• W2316657621 creator A5031935026 @default.
• W2316657621 creator A5051796682 @default.
• W2316657621 creator A5059501705 @default.
• W2316657621 date "2015-08-01" @default.
• W2316657621 modified "2023-10-16" @default.
• W2316657621 title "Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes" @default.
• W2316657621 cites W1863227821 @default.
• W2316657621 cites W1965427258 @default.
• W2316657621 cites W1994939857 @default.
• W2316657621 cites W2002935051 @default.
• W2316657621 cites W2017495882 @default.
• W2316657621 cites W2024208946 @default.
• W2316657621 cites W2047034979 @default.
• W2316657621 cites W2048939997 @default.
• W2316657621 cites W2052066020 @default.
• W2316657621 cites W2052089361 @default.
• W2316657621 cites W2054027726 @default.
• W2316657621 cites W2058853928 @default.
• W2316657621 cites W2060484926 @default.
• W2316657621 cites W2068961636 @default.
• W2316657621 cites W2075441588 @default.
• W2316657621 cites W2076669363 @default.
• W2316657621 cites W2078676951 @default.
• W2316657621 cites W2081337814 @default.
• W2316657621 cites W2100928326 @default.
• W2316657621 cites W2110169860 @default.
• W2316657621 cites W2110578052 @default.
• W2316657621 cites W2115298715 @default.
• W2316657621 cites W2126717458 @default.
• W2316657621 cites W2148876744 @default.
• W2316657621 cites W2162543839 @default.
• W2316657621 cites W2167484086 @default.
• W2316657621 cites W2413240184 @default.
• W2316657621 cites W563974518 @default.
• W2316657621 cites W628257392 @default.
• W2316657621 doi "https://doi.org/10.1097/md.0000000000001359" @default.
• W2316657621 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4616694" @default.
• W2316657621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26266392" @default.
• W2316657621 hasPublicationYear "2015" @default.
• W2316657621 type Work @default.
• W2316657621 sameAs 2316657621 @default.
• W2316657621 citedByCount "50" @default.
• W2316657621 countsByYear W23166576212016 @default.
• W2316657621 countsByYear W23166576212017 @default.
• W2316657621 countsByYear W23166576212018 @default.
• W2316657621 countsByYear W23166576212019 @default.
• W2316657621 countsByYear W23166576212020 @default.
• W2316657621 countsByYear W23166576212021 @default.
• W2316657621 countsByYear W23166576212022 @default.
• W2316657621 countsByYear W23166576212023 @default.
• W2316657621 crossrefType "journal-article" @default.
• W2316657621 hasAuthorship W2316657621A5031935026 @default.
• W2316657621 hasAuthorship W2316657621A5051796682 @default.
• W2316657621 hasAuthorship W2316657621A5059501705 @default.
• W2316657621 hasBestOaLocation W23166576211 @default.
• W2316657621 hasConcept C117220453 @default.
• W2316657621 hasConcept C121608353 @default.
• W2316657621 hasConcept C126322002 @default.
• W2316657621 hasConcept C142724271 @default.
• W2316657621 hasConcept C143998085 @default.
• W2316657621 hasConcept C191093355 @default.
• W2316657621 hasConcept C195121873 @default.
• W2316657621 hasConcept C2524010 @default.
• W2316657621 hasConcept C2776372563 @default.
• W2316657621 hasConcept C2776667971 @default.
• W2316657621 hasConcept C2777546739 @default.
• W2316657621 hasConcept C2780849966 @default.
• W2316657621 hasConcept C29456083 @default.
• W2316657621 hasConcept C2993294228 @default.
• W2316657621 hasConcept C3018521938 @default.
• W2316657621 hasConcept C3020375857 @default.
• W2316657621 hasConcept C33923547 @default.
• W2316657621 hasConcept C526584372 @default.
• W2316657621 hasConcept C530470458 @default.
• W2316657621 hasConcept C71924100 @default.
• W2316657621 hasConcept C84606932 @default.
• W2316657621 hasConceptScore W2316657621C117220453 @default.
• W2316657621 hasConceptScore W2316657621C121608353 @default.
• W2316657621 hasConceptScore W2316657621C126322002 @default.
• W2316657621 hasConceptScore W2316657621C142724271 @default.
• W2316657621 hasConceptScore W2316657621C143998085 @default.
• W2316657621 hasConceptScore W2316657621C191093355 @default.
• W2316657621 hasConceptScore W2316657621C195121873 @default.
• W2316657621 hasConceptScore W2316657621C2524010 @default.
• W2316657621 hasConceptScore W2316657621C2776372563 @default.
• W2316657621 hasConceptScore W2316657621C2776667971 @default.
• W2316657621 hasConceptScore W2316657621C2777546739 @default.
• W2316657621 hasConceptScore W2316657621C2780849966 @default.
• W2316657621 hasConceptScore W2316657621C29456083 @default.
• W2316657621 hasConceptScore W2316657621C2993294228 @default.
• W2316657621 hasConceptScore W2316657621C3018521938 @default.
• W2316657621 hasConceptScore W2316657621C3020375857 @default.
• W2316657621 hasConceptScore W2316657621C33923547 @default.
• W2316657621 hasConceptScore W2316657621C526584372 @default.
• W2316657621 hasConceptScore W2316657621C530470458 @default.
• W2316657621 hasConceptScore W2316657621C71924100 @default.

• next